The problem here is the idea that medicines have a particular price. In reality you have a very big bill for developing it. A substantial bill for tooling up

The problem here is the idea that medicines have a particular price. In reality you have a very big bill for developing it. A substantial bill for tooling up to actually be able to produce it. And typically a small bill for each unit you produce. Now, I would like to see the developed world all pay the same price. But it wouldn't end up being the UHC-negotiated rates. I actually consider negotiation (or this dictate pretending to be negotiation) a bad thing. Instead: You must sell to the US market at a rate no greater than you sell to any developed country. This is measured as net $ vs doses. No playing games with rebates, no playing games with giving them some for free. Reciprocity is encouraged, make the playing field level. The US would benefit, the rest of the developed world would be screaming bloody murder.